KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Deferred Taxes (2016 - 2025)

Johnson & Johnson's Deferred Taxes history spans 17 years, with the latest figure at -$3.7 billion for Q4 2025.

  • For Q4 2025, Deferred Taxes fell 22881.25% year-over-year to -$3.7 billion; the TTM value through Dec 2025 reached $1.5 billion, up 170.45%, while the annual FY2025 figure was $1.5 billion, 170.45% up from the prior year.
  • Deferred Taxes for Q4 2025 was -$3.7 billion at Johnson & Johnson, down from $2.2 billion in the prior quarter.
  • Across five years, Deferred Taxes topped out at $2.2 billion in Q3 2025 and bottomed at -$3.7 billion in Q4 2025.
  • The 5-year median for Deferred Taxes is -$712.5 million (2021), against an average of -$462.8 million.
  • The largest YoY upside for Deferred Taxes was 2364.44% in 2025 against a maximum downside of 22881.25% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$1.9 billion in 2021, then skyrocketed by 50.72% to -$926.0 million in 2022, then crashed by 160.48% to -$2.4 billion in 2023, then surged by 99.34% to -$16.0 million in 2024, then tumbled by 22881.25% to -$3.7 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Deferred Taxes are -$3.7 billion (Q4 2025), $2.2 billion (Q3 2025), and $825.0 million (Q2 2025).